GlaxoSmithKline Pharmaceuticals Ltd represents values and a corporate philosophy centered on innovation, integrity, and patient-focused healthcare. As a leading pharmaceutical company, GlaxoSmithKline is committed to discovering, developing, and delivering high-quality medicines that improve people's lives. Their philosophy revolves around ethical business practices, stringent quality standards, and adherence to regulatory norms. By leveraging cutting-edge research and technology, GlaxoSmithKline aims to address critical healthcare challenges and contribute to societal well-being. With a strong emphasis on sustainability, they are dedicated to reducing environmental impact and promoting responsible business practices. GlaxoSmithKline Pharmaceuticals Ltd's relentless pursuit of scientific excellence and commitment to serving patients underscores their reputation as a trusted and renowned pharmaceutical entity.

GlaxoSmithKline Pharmaceuticals Ltd is primarily present in various countries and regions. The company has a strong global presence and operates in multiple markets. Some of the key countries where GlaxoSmithKline Pharmaceuticals Ltd has a significant presence include the United Kingdom, United States, India, China, Japan, Australia, the European Union, and many more. With its extensive reach, GlaxoSmithKline Pharmaceuticals Ltd continues to expand its operations and serve customers in diverse geographical locations.

GlaxoSmithKline Pharmaceuticals Ltd has achieved several significant milestones. Notably, the company has consistently demonstrated its commitment to innovation and has been at the forefront of discovering and developing life-saving medications. With a strong focus on research and development, GlaxoSmithKline Pharmaceuticals Ltd has successfully launched numerous breakthrough drugs that have revolutionized healthcare. Additionally, the company has maintained a stellar track record in ensuring high-quality and affordable pharmaceutical products for patients across the globe. With its unwavering dedication to advancing healthcare, GlaxoSmithKline Pharmaceuticals Ltd continues to achieve remarkable milestones in improving the overall well-being of people worldwide.

GlaxoSmithKline Pharmaceuticals Ltd, a leading pharmaceutical company, has a rich history and background. Established in 1924, it has evolved into a trusted healthcare provider. GlaxoSmithKline Pharmaceuticals specializes in the research, development, and manufacturing of innovative medicines and vaccines. With a strong presence in India, it has played a pivotal role in the country's healthcare sector. As a subsidiary of GlaxoSmithKline plc, a global pharmaceutical company, it benefits from the extensive expertise and resources of its parent company. GlaxoSmithKline Pharmaceuticals is dedicated to enhancing the quality of life and contributing to the well-being of individuals through its cutting-edge healthcare solutions.

The main competitors of GlaxoSmithKline Pharmaceuticals Ltd in the market are Sun Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories Ltd, and Cipla Ltd.

GlaxoSmithKline Pharmaceuticals Ltd is primarily active in the pharmaceutical industry.

The business model of GlaxoSmithKline Pharmaceuticals Ltd is focused on the research, development, manufacturing, and marketing of pharmaceutical products. As a leading pharmaceutical company, GlaxoSmithKline Pharmaceuticals Ltd produces a wide range of medicines across various therapeutic areas, including respiratory, anti-infective, dermatology, and more. The company aims to improve the quality of human life by delivering innovative and high-quality healthcare solutions. With a strong commitment to research and development, GlaxoSmithKline Pharmaceuticals Ltd strives to address unmet medical needs and provide accessible and affordable healthcare options to patients worldwide.

مُعامل القيمة السوقية إلى الأرباح لـ GlaxoSmithKline Pharmaceuticals هو ٧٠٫٥٦.

مُعامِل القيمة إلى المبيعات GlaxoSmithKline Pharmaceuticals هو ١٢٫٠٥.

نقاط جودة AlleAktien لـ GlaxoSmithKline Pharmaceuticals هي 9/10.

GlaxoSmithKline Pharmaceuticals الإيرادات هي ٣٤٫٥٤ مليارات INR.

صافي الربح GlaxoSmithKline Pharmaceuticals هو ٥٫٩٠ مليارات INR.

The company GlaxoSmithKline Pharmaceuticals Ltd is a global company that manufactures and distributes various health products and pharmaceuticals. It was founded in 2000 through the merger of the British pharmaceutical company GlaxoWellcome and the American corporation SmithKline Beecham. The business model of GlaxoSmithKline Pharmaceuticals is based on the production of prescription and over-the-counter medications for various therapeutic areas. The company is divided into three divisions: Pharma, Vaccines, and Consumer Healthcare. In the Pharma division, GlaxoSmithKline manufactures innovative medications for areas such as oncology, diabetes, and respiratory diseases. These are primarily prescription drugs prescribed by doctors. The Vaccine division develops and produces vaccines for different infectious diseases such as meningitis or HPV. Consumer Healthcare, on the other hand, offers over-the-counter medications for colds, pain, and gastrointestinal issues. Some of the well-known medications produced by GlaxoSmithKline Pharmaceuticals include Zovirax (for herpes), Advair (for asthma), Voltaren (for pain), and Panadol (for pain and fever). The company also has products for HIV/AIDS therapy, such as Tivicay. In the Vaccine division, the company offers products such as Hepatitis A and B vaccines, the HPV vaccine Cervarix, and the pneumococcal vaccine Synflorix. Consumer Healthcare distributes over-the-counter products such as Otrivin (for nasal congestion), Nicorette (for smoking cessation), and Sensodyne (for sensitive teeth). The company continuously invests in research and development to develop new medications and improve existing products. In 2019, GlaxoSmithKline Pharmaceuticals' research and development budget was almost 4 billion euros. Additionally, the company works closely with government agencies and other partners to combat global health issues. For example, GlaxoSmithKline Pharmaceuticals is involved in an immunization program for children in developing countries. The company distributes its products worldwide, operating in more than 150 countries. The company's headquarters are located in Brentford, United Kingdom. It also has a presence in Germany, with a location in Munich. In summary, GlaxoSmithKline Pharmaceuticals Ltd is a leading company in the pharmaceutical and healthcare products industry. Its business model is based on the production of prescription and over-the-counter medications as well as vaccines. The company's close collaboration with government agencies and partners makes it an important player in the fight against global health issues.

يوزع GlaxoSmithKline Pharmaceuticals أرباحًا قدرها ٣٠٫٠٠ INR من خلال عمليات توزيع موزعة على مدار السنة.

لا يمكن حساب الأرباح السنوية لـ GlaxoSmithKline Pharmaceuticals في الوقت الحالي أو أن الشركة لا توزع أرباحًا.

الرمز الدولي للأوراق المالية الخاص بـGlaxoSmithKline Pharmaceuticals هو INE159A01016.

الرمز المُختصر لـ GlaxoSmithKline Pharmaceuticals هو GLAXO.NS.

خلال آخر 12 شهراً، دفعت GlaxoSmithKline Pharmaceuticals توزيعات أرباح بقيمة ٤٤٫٠٠ INR . وهذا يعادل عائد توزيعات أرباح يقارب ١٫٧٩ %. ومن المتوقع أن تدفع GlaxoSmithKline Pharmaceuticals خلال الـ12 شهراً القادمة توزيعات أرباح تقدر بـ٤١٫٧٠ INR.

نسبة توزيعات الأرباح الحالية لـ GlaxoSmithKline Pharmaceuticals هي ١٫٧٩ %.

GlaxoSmithKline Pharmaceuticals يدفع توزيعات أرباح ربع سنوية. يتم توزيعها في الأشهر أغسطس, يوليو, يونيو, ديسمبر.

GlaxoSmithKline Pharmaceuticals دفعت توزيعات الأرباح كل عام خلال الـ23 سنوات الماضية.

يُتوقع خلال الـ12 شهرًا القادمة توزيع أرباح بقيمة ٤١٫٧٠ INR. وهذا يعادل عائد توزيعات أرباح قدره ١٫٧٠ %.

GlaxoSmithKline Pharmaceuticals يُصنف ضمن قطاع 'الصحة'.

لكي تستلم آخر توزيعات أرباح بقيمة ١٢ INR من GlaxoSmithKline Pharmaceuticals المُعلن عنها في ٢٨‏/١١‏/٢٠٢٤، كان يجب أن تمتلك السهم في محفظتك قبل تاريخ الاستحقاق السابق في ٧‏/١١‏/٢٠٢٤.

تم توزيع آخر دفعة من الأرباح بتاريخ ٢٨‏/١١‏/٢٠٢٤.

في العام 2023، وزعت GlaxoSmithKline Pharmaceuticals ٣٢ INR كأرباح أسهم.

يتم توزيع أرباح GlaxoSmithKline Pharmaceuticals بالعملة INR.